87 related articles for article (PubMed ID: 7878810)
1. Excellent kidney graft survival in patients with high pretransplant serum IgA concentrations and IgA-anti-Fab autoantibody activity.
Süsal C; Wiesel M; Staehler G; Groth J; May G; Opelz G
Transplant Proc; 1995 Feb; 27(1):1072-4. PubMed ID: 7878810
[No Abstract] [Full Text] [Related]
2. Pretransplant IgA-anti-hinge and IgA-anti-Fab autoantibody activity is associated with good kidney graft survival.
Süsal C; Kröpelin M; Wiesel M; Staehler G; Groth J; May G; Opelz G
Transplant Proc; 1995 Oct; 27(5):2663-5. PubMed ID: 7482869
[No Abstract] [Full Text] [Related]
3. Pretransplant serum IgA concentration and IgA-anti-Fab autoantibody activity as prognostic indicators of kidney graft survival.
Süsal C; Dörr C; Groth J; May G; Opelz G
Transpl Int; 1994; 7 Suppl 1():S586-9. PubMed ID: 11271315
[TBL] [Abstract][Full Text] [Related]
4. Pretransplant serum IgA concentration and IgA-anti-Fab autoantibody activity in living donor renal transplant recipients: a pilot study.
Kim MS; Kim YS; Kim SI; Lee JW; Moon JI; Park K
Transplant Proc; 1998 Nov; 30(7):2977-8. PubMed ID: 9838314
[No Abstract] [Full Text] [Related]
5. Presensitization and HLA match influence the predictive power of pretransplant serum IgA and IgA-anti-Fab autoantibodies in kidney graft recipients.
Süsal C; Wiesel M; Schönemann C; Groth J; Carl S; Staehler G; May G; Opelz G
Transplant Proc; 1997; 29(1-2):1444-6. PubMed ID: 9123373
[No Abstract] [Full Text] [Related]
6. Characterization of protective anti-Fab autoantibodies in kidney graft recipients.
Süsal C; Groth J; Tanzi-Fetta RF; Kirste G; Doerr C; Terness P; May G; Staehler G; Opelz G
Transplant Proc; 1992 Dec; 24(6):2523-6. PubMed ID: 1465853
[No Abstract] [Full Text] [Related]
7. Kidney graft recipients with pretransplantation HLA CLASS I antibodies and high soluble CD30 are at high risk for graft loss.
Rodríguez LM; París SC; Arbeláez M; Cotes JM; Süsal C; Torres Y; García LF
Hum Immunol; 2007 Aug; 68(8):652-60. PubMed ID: 17678719
[TBL] [Abstract][Full Text] [Related]
8. Early post-transplant immune monitoring can predict long-term kidney graft survival: soluble CD30 levels, anti-HLA antibodies and IgA-anti-Fab autoantibodies.
Amirzargar MA; Amirzargar A; Basiri A; Hajilooi M; Roshanaei G; Rajabi G; Mohammadiazar S; Solgi G
Hum Immunol; 2014 Jan; 75(1):47-58. PubMed ID: 24055694
[TBL] [Abstract][Full Text] [Related]
9. [Illness stage and IgA-anti-Fab/F(ab')2 autoantibody activity in serum of patients with malignant head-neck tumors].
Lorenz KJ; Süsal C; Opelz G; Maier H
Laryngorhinootologie; 1996 Dec; 75(12):764-8. PubMed ID: 9081283
[TBL] [Abstract][Full Text] [Related]
10. A natural IgA-anti-F(ab')2gamma autoantibody occurring in healthy individuals and kidney graft recipients recognizes an IgG1 hinge region epitope.
Terness P; Navolan D; Moroder L; Siedler F; Weyher E; Kohl I; Dufter C; Welschof M; Drugarin D; Schneider F; Opelz G
J Immunol; 1996 Nov; 157(9):4251-7. PubMed ID: 8892664
[TBL] [Abstract][Full Text] [Related]
11. Pre- and Posttransplant IgA Anti-Fab Antibodies to Predict Long-term Kidney Graft Survival.
Amirzargar MA; Amirzargar A; Basiri A; Hajilooi M; Roshanaei G; Rajabi G; Solgi G
Transplant Proc; 2015 May; 47(4):1110-3. PubMed ID: 26036531
[TBL] [Abstract][Full Text] [Related]
12. Association of anti-Fab and anti-IgG antibodies with high kidney transplant survival.
Chia D; Horimi T; Terasaki PI; Hermes M
Transplant Proc; 1982 Jun; 14(2):322-4. PubMed ID: 7051474
[TBL] [Abstract][Full Text] [Related]
13. IgA class antibodies and flow cytometric cross-matching in renal transplantation.
Doran TJ; Süsal C; Opelz G; Geczy AF
Transplantation; 1999 Jan; 67(2):309-14. PubMed ID: 10075600
[TBL] [Abstract][Full Text] [Related]
14. Graft-protective role of high pretransplantation IgA-anti-Fab autoantibodies: confirmatory evidence obtained in more than 4000 kidney transplants. The Collaborative Transplant Study.
Süsal C; Döhler B; Opelz G
Transplantation; 2000 Apr; 69(7):1337-40. PubMed ID: 10798750
[TBL] [Abstract][Full Text] [Related]
15. Predictive value of pretransplant inflammatory markers in renal allograft survival and rejection in children.
Butani L; Johnson J; Troppmann C; McVicar J; Perez RV
Transplant Proc; 2005 Mar; 37(2):679-81. PubMed ID: 15848499
[TBL] [Abstract][Full Text] [Related]
16. Reappraisal of HLA antibody analysis and crossmatching in kidney transplantation.
Lee PC; Ozawa M
Clin Transpl; 2007; ():219-26. PubMed ID: 18642453
[TBL] [Abstract][Full Text] [Related]
17. Autoimmune component in individuals during immune response to inactivated combined vaccine against Q fever.
Krutitskaya L; Tokarevich N; Zhebrun A; Kartseva N; Tarasevich I; Yablonskaya V; Fatalieva S; Misnikov OP; Vasilenko AZ
Acta Virol; 1996 Sep; 40(4):173-7. PubMed ID: 9014006
[TBL] [Abstract][Full Text] [Related]
18. Effect of anti-Fab antibodies on renal allografts.
Feduska NJ; Chia D; Terasaki PI; Sugich L
Transplant Proc; 1991 Feb; 23(1 Pt 2):1277-8. PubMed ID: 1989211
[No Abstract] [Full Text] [Related]
19. Pretransplant positivity for circulating thyroid antibodies and graft survival in patients undergoing kidney transplant.
Rotondi M; Leporati P; Lodigiani S; Netti GS; Precerutti S; Magri F; Rosati A; Pradella F; Salvadori M; Serio M; Romagnani P; Chiovato L
Horm Res; 2009; 71(6):324-30. PubMed ID: 19506389
[TBL] [Abstract][Full Text] [Related]
20. Pretransplant detection of anti-endothelial cell antibodies could predict renal allograft outcome.
Ismail AM; Badawi RM; El-Agroudy AE; Mansour MA
Exp Clin Transplant; 2009 Jun; 7(2):104-9. PubMed ID: 19715514
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
